Cargando…
The availability of drug by liposomal drug delivery: Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate
Lately, the usefulness of liposomal drug delivery systems has been debated. To better understand the underlying pharmacokinetics of the targeted drug delivery by liposomes, individual encapsulated and non-encapsulated drug concentrations in blood, tumor, liver, spleen and kidneys were quantified aft...
Autores principales: | Smits, Evelien A. W., Soetekouw, José A., Pieters, Ebel H. E., Smits, Coen J. P., de Wijs-Rot, Nicolette, Vromans, Herman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736927/ https://www.ncbi.nlm.nih.gov/pubmed/30547315 http://dx.doi.org/10.1007/s10637-018-0708-4 |
Ejemplares similares
-
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
por: O’Donnell, Robert T., et al.
Publicado: (2009) -
Hydrophobic Drug-Loaded PEGylated Magnetic Liposomes for Drug-Controlled Release
por: Hardiansyah, Andri, et al.
Publicado: (2017) -
Tumor Burden Talks in Cancer Treatment with PEGylated Liposomal Drugs
por: Lin, Yi-Yu, et al.
Publicado: (2013) -
PEGylated liposomes enhance the effect of cytotoxic drug: A review
por: Taher, Muhammad, et al.
Publicado: (2023) -
Maleimide-Decorated PEGylated Mucoadhesive Liposomes
for Ocular Drug Delivery
por: Moiseev, Roman V., et al.
Publicado: (2022)